Skip to content

Clinical trials

Observational trials in China with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Observational Status: Unknown status Country / region: China Clear all

4,463 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20012
20021
20034
20044
20055
20068
200717
200825
200930
201059
201166
2012101
2013102
2014120
2015144
2016251
2017327
2018360
2019388
2020468
2021564
2022631
2023561
2024213
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4,463

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University Third Hospital154
Peking Union Medical College Hospital152
Sun Yat-sen University136
Second Affiliated Hospital, Zhejiang University, School of Medicine129
Nanfang Hospital, Southern Medical University82
Shanghai Zhongshan Hospital81
RenJi Hospital75
Fudan University72
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University70
First Affiliated Hospital Xi'an Jiaotong University68

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms130
Lung Neoplasms94
Carcinoma, Hepatocellular93
Carcinoma, Non-Small-Cell Lung91
Stomach Neoplasms91
Colorectal Neoplasms86
Disease84
Coronary Artery Disease73
COVID-1972
Sepsis67

Trials

Showing 1 to 25 of 4,463. Each trial links to its page on Pharma Observatory.

4,363 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.